Analysis of porcine circovirus type 1 detected in Rotarix vaccine

Vaccine

Volumn 29, Issue 4, 2011, Pages 690-697

  Baylis, Sally A ^a   Finsterbusch, Tim ^b   Bannert, Norbert ^b   Blümel, Johannes ^a   Mankertz, Annette ^b  

^a PAUL EHRLICH INSTITUT   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Adventitious agents; Porcine circovirus; Rotarix vaccine

Indexed keywords

NUCLEIC ACID; ROTAVIRUS VACCINE; VIRUS DNA;

ANIMAL CELL; ARTICLE; CIRCOVIRUS; CONTROLLED STUDY; EXTRACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INCUBATION TIME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS TRANSCRIPTION;

ANIMALS; CELL LINE; CIRCOVIRUS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROTAVIRUS VACCINES; VACCINES, ATTENUATED; VIRAL LOAD;

EID: 78650533823     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.028     Document Type: Article

References (27)

1. Anderson E.J. Prevention and treatment of viral diarrhea in pediatrics. Expert Rev Anti Infect Ther 2010, 8:205-217.
2. Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010, 201:1617-1624.
3. Tate J.E., Patel M.M., Steele A.D., Gentsch J.R., Payne D.C., Cortese M.M., et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010, 9:395-407.
4. Reduction in rotavirus after vaccine introduction - United States, 2000-2009. MMWR Morb Mortal Wkly Rep 2009;58:1146-9.
5. Victoria J.G., Wang C., Jones M.S., Jaing C., McLoughlin K., Gardner S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84:6033-6040.
6. Baylis S.A., Shah N., Minor P.D. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Meth 2004, 121:7-16.
7. Koppelman M.H., Rood I.R., Fryer J.F., Baylis S.A., Cuypers H.T. Parvovirus B19 genotype 1 and 2 detection with real-time PCR assays. Vox Sang 2007, 93:208-215.
8. Hattermann K., Roedner C., Schmitt C., Finsterbusch T., Steinfeldt T., Mankertz A. Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2. Xenotransplantation 2004, 11:284-294.
9. Tischer I., Bode L., Apodaca J., Timm H., Peters D., Rasch R., et al. Presence of antibodies reacting with porcine circovirus in sera of humans, mice, and cattle. Arch Virol 1995, 140:1427-1439.
10. Allan G.M., McNeilly F., Cassidy J.P., Reilly G.A., Adair B., Ellis W.A., et al. Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material. Vet Microbiol 1995, 44:49-64.
11. Ellis J.A., Wiseman B.M., Allan G., Konoby C., Krakowka S., Meehan B., et al. Analysis of seroconversion to porcine circovirus 2 among veterinarians from the United States and Canada. J Am Vet Med Assoc 2000, 217:1645-1646.
12. Hattermann K., Maerz A., Slanina H., Schmitt C., Mankertz A. Assessing the risk potential of porcine circoviruses for xenotransplantation: consensus primer-PCR-based search for a human circovirus. Xenotransplantation 2004, 11:547-550.
13. Li L., Kapoor A., Slikas B., Bamidele O.S., Wang C., Shaukat S., et al. Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces. J Virol 2010, 84:1674-1682.
14. Fenaux M., Opriessnig T., Halbur P.G., Xu Y., Potts B., Meng X.J. Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product. J Gen Virol 2004, 85:3377-3382.
15. O'Ryan M., Linhares A.C. Update on Rotarix: an oral human rotavirus vaccine. Expert Rev Vaccines 2009, 8:1627-1641.
16. Howe B. GSK's PCV1 investigation. Vaccines and related biological products advisory committee meeting presentations 2010, http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/ucm211828.htm.
17. Committee for Medicinal Products for Human Use. Questions and answers on the review of Rotarix (rotavirus vaccine, live) EMA/CHMP/460465.; 2010. http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2010/07/WC500094832.pdf.
18. Rotarix, rotavirus vaccine, live. EPAR summary for the public. EMEA/526825.; 2009. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000639/WC500054587.pdf.
19. Krause P.R. CBER assessment of porcine circovirus in vaccines. Vaccines and Related Biological Products Advisory Committee Meeting Presentations 2010, http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/ucm211828.htm.
20. Boyle J.F., Holmes K.V. RNA-binding proteins of bovine rotavirus. J Virol 1986, 58:561-568.
21. Labbé M., Baudoux P., Charpilienne A., Poncet D., Cohen J. Identification of the nucleic acid binding domain of the rotavirus VP2 protein. J Gen Virol 1994, 75:3423-3430.
22. Allan G.M., Phenix K.V., Todd D., McNulty M.S. Some biological and physico-chemical properties of porcine circovirus. Zentralbl Veterinarmed B 1994, 41:17-26.
23. Plavsic Z.M., Bolin S. Resistance of porcine circo virus to gamma irradiation. BioPharm 2001, April 32-36.
24. U.S. Food and Drug Administration Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications 2010, FDA Center for Biologics Evaluation and Research, Rockville, MD, Guidance for Industry http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
25. Council of Europe: 2.6.16 Tests for extraneous agents in viral vaccines for human use. In: European Pharmacopoeia. 6th ed. Strasbourg, France: Council of Europe; 2008.
26. Quintana J., Segalés J., Calsamiglia M., Domingo M. Detection of porcine circovirus type 1 in commercial pig vaccines using polymerase chain reaction. Vet J 2006, 171:570-573.
27. Onions D., Kolman J. Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 2010, 38:377-380.